SCHEMBL14636285

SCHEMBL14636285

CCOC(=O)CN(C)C(=O)Cc1cc(Cl)ccc1Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.44
L3MBTL1 Q9Y468 4/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CHRM1 P11229 1/20 0.41
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
LTB4R Q15722 3/20 0.40
LTB4R2 Q9NPC1 3/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10093029 0.90 L3MBTL1 (0.44) NPSR1L3MBTL1GAAMAPTALDH1A1
SCHEMBL9995320 0.86 SLC6A4 (0.52) MAPTCHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL13752339 0.83 L3MBTL1 (0.43) NPSR1L3MBTL1GAAMAPTALDH1A1
SCHEMBL967886 0.77 L3MBTL1 (0.51) NPSR1L3MBTL1MAPTALDH1A1CHRM1
SCHEMBL9995153 0.77 PPARG (0.40) NPSR1L3MBTL1GAAMAPTALDH1A1
SCHEMBL7400584 0.76 CHRM1 (0.65) NPSR1L3MBTL1MAPTCHRM1SLC6A4
SCHEMBL872624 0.76 SLC6A4 (0.53) L3MBTL1MAPTALDH1A1CHRM1SLC6A2
SCHEMBL878121 0.75 SLC6A4 (0.47) MAPTCHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL12929644 0.75 CYP1A2 (0.57) MAPTCHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL8471261 0.72 SLC6A4 (0.58) MAPTCHRM1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9145421-B2 Process for the preparation of asenapine maleate RANBAXY LABORATORIES LIMITED (IN) 2015-09-29 US disclosed
US-20150112083-A1 PROCESS FOR THE PREPARATION OF ASENAPINE MALEATE RANBAXY LABORATORIES LIMITED (IN) 2015-04-23 US disclosed
WO-2013011461-A1 PROCESS FOR THE PREPARATION OF ASENAPINE MALEATE RANBAXY LABORATORIES LIMITED (IN) 2013-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150112083-A1 PROCESS FOR THE PREPARATION OF ASENAPINE MALEATE DHPS, SCN5A, CYP3A5 NPSR1 818/4885L3MBTL1 4817/4885GAA 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.